THUY TRAN: Open Payments
NPI 1376092155 · GULFPORT, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$890 in 47 payments from 14 companies in 2025. Trend: 2023 $700 · 2024 $1,218 · 2025 $890
Food & beverage: $835Education: $55
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 15 | $247 |
| UCB, Inc. | 11 | $172 |
| Regeneron Healthcare Solutions, Inc. | 5 | $90 |
| Janssen Biotech, Inc. | 2 | $75 |
| Organon LLC | 2 | $52 |
| Novartis Pharmaceuticals Corporation | 2 | $39 |
| Amgen Inc. | 2 | $36 |
| LEO Pharma Inc. | 2 | $35 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $31 |
| GENZYME CORPORATION | 1 | $28 |
Products named: NEMLUVIO, Bimzelx, DUPIXENT, TREMFYA, OTEZLA, ILUMYA, ACTHAR, SOFDRA.
Industry payments across MS — which companies pay providers there.
